Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds – National
The drug tirzepatide, made popular for its treatment of Type 2 diabetes and weight loss, lowers the risk of progression to diabetes by 94 per cent among adults with prediabetes …